BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9142431)

  • 1. New inotropic concepts: rationale for and differences between calcium sensitizers and phosphodiesterase inhibitors.
    Holubarsch C
    Cardiology; 1997; 88 Suppl 2():12-20. PubMed ID: 9142431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
    Uhlmann R; Schwinger RH; Lues I; Erdmann E
    Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
    Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.
    Lues I; Beier N; Jonas R; Klockow M; Haeusler G
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of positive inotropes on the failing human myocardium.
    Erdmann E
    Cardiology; 1997; 88 Suppl 2():7-11. PubMed ID: 9142430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive inotropism and myocardial energetics: influence of beta receptor agonist stimulation, phosphodiesterase inhibition, and ouabain.
    Holubarsch C; Hasenfuss G; Just H; Alpert NR
    Cardiovasc Res; 1994 Jul; 28(7):994-1002. PubMed ID: 7954612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".
    Beier N; Harting J; Jonas R; Klockow M; Lues I; Haeusler G
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):17-27. PubMed ID: 1719287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
    Berger C; Meyer W; Scholz H; Starbatty J
    Arzneimittelforschung; 1985; 35(11):1668-73. PubMed ID: 2418846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Ca2+ signaling and Ca2+ sensitizers.
    Endoh M
    Circ J; 2008 Dec; 72(12):1915-25. PubMed ID: 18981594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of myothermal economy of isometric force generation by positive inotropic interventions in the guinea pig myocardium.
    Holubarsch CH; Hasenfuss G; Just H; Blanchard EM; Mulieri LA; Alpert NR
    Cardioscience; 1990 Mar; 1(1):33-41. PubMed ID: 2102794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of myocardial economy and efficiency in mammalian failing and non-failing myocardium by calcium channel activation and beta-adrenergic stimulation.
    Ruf T; Hebisch S; Gross R; Alpert N; Just H; Holubarsch C
    Cardiovasc Res; 1996 Dec; 32(6):1047-55. PubMed ID: 9015407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension.
    Haikala H; Levijoki J; Lindén IB
    J Mol Cell Cardiol; 1995 Oct; 27(10):2155-65. PubMed ID: 8576932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the positive inotropic substance pimobendan (UD-CG 115 BS) on contractile economy of guinea pig papillary muscles.
    Holubarsch C; Hasenfuss G; Just H; Blanchard E; Mulieri LA; Alpert NR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S13-7. PubMed ID: 2478786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac profile of EGIS-9377, a novel cardiotonic agent as a Ca2+ sensitizer with bradycardiac activity.
    Hattori Y; Ishitani T; Tomita F; Gando S; Yokoshiki H; Azuma M; Kemmotsu O; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):585-90. PubMed ID: 10598798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium.
    Bethke T; Meyer W; Schmitz W; Scholz H; Wenzlaff H; Armah BI; Brückner R; Raap A
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):847-55. PubMed ID: 7687707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
    Fujino K; Sperelakis N; Solaro RJ
    Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economy of contraction of cardiomyocytes as influenced by different positive inotropic interventions.
    Pöpping S; Mruck S; Fischer Y; Kulsch D; Ionescu I; Kammermeier H; Rose H
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H357-64. PubMed ID: 8760193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.